Overview

Andrew is an experienced Legal & Compliance counsel with 25 years' experience, across both private practice and inhouse legal roles in Tokyo, Basel, Sydney and Perth.  He has worked for the some of the largest pharma and biotech companies in the world for a combined period of around 13 years.  Andrew also has around 12 years' experience working for top-tier global law firms in connection with M&A transactions, joint ventures, drafting / negotiation of contracts, and provision of corporate and commercial advice.  Skilled in negotiation, drafting, licensing, M&A, FCPA / ABAC, pharma code compliance, data privacy and corporate governance. Andrew is fluent in both written and spoken in Japanese.

Education and Admission

1994    Japanese Government (Monbusho) Scholarship, Kagoshima University

1999    LL.B. / B.A. (Modern Asian Studies - Japanese), Griffith University

2000    Graduate Diploma of Legal Practice - College of Law, New South Wales

2000    Admitted as a Solicitor, New South Wales

2009    Admitted as a Solicitor, England and Wales

Work History

1999 - 2001    Minter Ellison Lawyers, Associate, Sydney

2001 - 2005    Baker & McKenzie (Corporate / M&A Dept), Associate, Tokyo

2005 - 2010    Allen & Overy (Corporate / M&A Dept), Senior Associate, Tokyo

2010               General Counsel Japan, Veolia Water Japan K.K., Tokyo

2011 - 2012    Novartis International AG, Senior Legal Counsel M&A, Basel

2012 - 2014    Corrs Chambers Westgarth, Senior Associate, Perth (* home jurisdiction experience)

2014 - 2017    Bayer Holding Ltd., Senior Legal Counsel, Tokyo

2017 - 2018    Alexion Pharma GK, Head of Legal & Compliance Japan, Tokyo

2018 – 2020    Alexion Pharma GK, Head of Legal Japan, Tokyo

2020 - 2024    Global Contracts Director – AstraZeneca, Alexion Rare Disease Business Unit

2024 - present   GI&T Law Office, LC, Counsel, Tokyo

Language

-      English, Japanese